Karolinska University Hospital
Sweden's leading cancer hospital, linked to the Karolinska Institutet and Nobel Assembly, with strong registry-based research.
Overview
Karolinska University Hospital in Stockholm is Sweden's leading cancer hospital, linked to the Karolinska Institutet and the Nobel Assembly, and ranks thirty-ninth in the Newsweek/Statista oncology list. Its Comprehensive Cancer Centre is known for registry-based research, because Sweden's national quality registries make real-world evidence and registry-randomised trials possible, and it collaborates with the Skandion proton clinic in Uppsala; Per Hall, Jonas Bergh and Thomas Helleday are among the people Nuclide lists. Nuclide links it to the ALASCCA aspirin trial, to the Swedish registry study of HPV vaccination and cervical cancer, and to ideas on randomising inside cancer registries and a registry-based MCED trial. Whether registry designs can carry regulatory weight outside the Nordics is the open question. Its registry and haematology programmes are listed below.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Karolinska University Hospital, including child institutions. 889 works · 11,706 citations · 82% open access · 10% clinical trials · 2% reviews.
- Ernesto Sparrelid88 works
- Poya Ghorbani65 works
- Hildur Helgadóttir51 works
- Bengt L. G. Glimelius36 works
- Bergþór Björnsson35 works
- Per Johan Nilsson34 works
- Marc G. Besselink33 works
- Lars Ny32 works
- Matthias J. Löhr32 works
- Jonas C. S. Bergh32 works
- Registry research
- Haematology